Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers.

<h4>Background</h4>Today, dementias are diagnosed late in the course of disease. Future treatments have to start earlier in the disease process to avoid disability requiring new diagnostic tools. The objective of this study is to develop a new method for the differential diagnosis and id...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Holger Jahn, Stefan Wittke, Petra Zürbig, Thomas J Raedler, Sönke Arlt, Markus Kellmann, William Mullen, Martin Eichenlaub, Harald Mischak, Klaus Wiedemann
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/375556f7b1884917910fff79f762f387
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!